Please provide your email address to receive an email when new articles are posted on . Epinephrine autoinjectors may have little effect on surviving anaphylaxis events. Research is needed in ...

The nasal spray Neffy is the first non-injectable epinephrine to treat the life-threatening allergic response ARS Pharmaceuticals, Inc. The first-ever needle-free alternative to the EpiPen and similar ...

Doctors prescribe EpiPen (epinephrine injection) to treat anaphylaxis from any cause, including food and medication allergies. Use EpiPen as soon as symptoms start or just after exposure to a known ...

The first non-injectable emergency treatment for allergies is anticipated to hit shelves following FDA approval of the neffy epinephrine nasal spray. The product from ARS Pharmaceuticals, previously ...

Misinformation and outdated protocols contribute to the suboptimal management of anaphylaxis by patients and healthcare professionals, based on data from two new studies presented at the American ...

Good news for those who suffer from severe allergic reactions: a nasal spray containing epinephrine rather than a needle can now treat those frightening moments. The treatment, called Neffy, was ...

Dr Ruchi Gupta attended the AAAAI/WAO conference in San Diego, where she explored key updates in anaphylaxis, angioedema, and chronic spontaneous urticaria (CSU). A major highlight was the consensus ...

neffy is the first epinephrine product approved for use out of a hospital setting in China for adults and children (>30 kg) living with severe allergic reactions Pediatrix Therapeutics, which has a ...

Please provide your email address to receive an email when new articles are posted on . Current guidelines have not been validated in infants and toddlers. Overlooked symptoms include flushing, ...